Prevention of squamous cell carcinoma

Myc inhibition in pre-clinical mouse models

Use of tobacco during cancer treatment

Immunotherapy in melanoma and other cancers

Next generation gene sequencing

Genomic signatures and predictive biomarkers in breast cancer

Next generation PI3 kinase inhibition

The aims of the WIN Consortium

Targeting tumour suppressor genes

Closing the cancer divide: Implementing the diagonal approach

Genome-wide methylation patterns suggest differences in breast cancer biology in American women of African and European ancestry

Racial disparities in cancer outcomes

Vitamin D and cancer prevention

Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma

Potential novel inhibitor to overcome drug resistance induced by RAF, MEK Inhibitors

Sapacitabine and seliciclib, antitumour activity in patients with incurable BRCA-deficient cancers

AKT inhibitor AZD5363 in patients with advanced solid tumours